United States Closed System Transfer Devices Market

By type, the US CSTDs market is segmented into membrane-to-membrane systems and needleless systems. Among these, membrane-to-membrane systems held the largest share of the US CSTD market in 2025 because their interlocking membrane design provides effective containment during hazardous-drug transfer. The system creates a closed pathway between components, helping minimize drug leakage, vapor escape, and environmental contamination. The membrane-to-membrane technology also enables needle-free connections, reducing needlestick exposure during repeated vial, syringe, and administration transfers. Its established use across oncology pharmacy workflows, availability from leading CSTD manufacturers, and compatibility with commonly used drug-transfer components have supported widespread adoption. These advantages make membrane-to-membrane systems particularly suitable for hazardous-drug preparation and administration.

By component, the market is segmented into vial access components, male Luers, bag spikes, female components, and other components. Among these, female components accounted for the largest share of the US CSTD market in 2025 because they serve as critical connection interfaces throughout hazardous drug preparation and administration workflows. These components connect syringes, vial access devices, infusion bags, administration sets, and other CSTD elements while maintaining system closure. Their utilization across multiple transfer stages generates recurring demand compared with components used in more specific applications. Female components are also available in Luer-lock and needleless configurations, enabling compatibility with existing hospital medication delivery infrastructure. Their broad applicability, repeated use, and integration with different CSTD systems support their leading market position.

By closing mechanism, the US CSTD market is segmented into Luer lock systems, push-to-turn systems, click-to-lock systems, and color-to-color alignment systems. Among these, the Luer lock systems segment held the largest share in 2025 due to its widespread use across syringes, vial adapters, infusion sets, and needleless connectors. Its threaded connection provides secure attachment and reduces accidental disconnection during hazardous-drug preparation and administration. Luer lock interfaces also offer compatibility with existing medication-delivery infrastructure, minimizing workflow modifications and staff retraining. Established familiarity among healthcare professionals, broad availability of compatible components, and integration across multiple CSTD configurations further support adoption, making Luer lock systems the preferred closing mechanism in US healthcare facilities.

Based on technology, the US CSTD market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. Among these, the diaphragm-based devices segment held the largest share of the US CSTD market in 2025 because their resealing mechanism provides a reliable barrier against hazardous-drug leakage, vapor escape, and external contamination. The diaphragm automatically closes after disconnection, helping maintain containment during repeated drug-transfer activities. This technology can be incorporated into vial adapters, syringe connectors, and administration components, enabling broad application across pharmacy and nursing workflows. Its relatively straightforward operating mechanism, established commercial availability, and compatibility with commonly used CSTD components have encouraged adoption among healthcare facilities. The technology’s focus on containment and ease of use further supports its market dominance.

Based on end users, the market is divided into hospitals and clinics, oncology centers, and other end users. Among these, the hospitals and clinics segment held the largest share of the US CSTD market in 2025 because they conduct substantial volumes of hazardous-drug preparation and administration, particularly for oncology patients. These facilities employ pharmacists, pharmacy technicians, nurses, and other healthcare professionals who may encounter hazardous drugs during routine workflows, creating strong demand for exposure-control measures. Hospitals also have centralized pharmacies and established procurement systems that facilitate CSTD adoption across multiple departments. Increasing emphasis on occupational safety, hazardous-drug handling practices, and compliance with applicable standards further supports utilization. Consequently, hospitals and clinics represent the largest and most established end-user base for CSTDs.